Developer of patient identification technology platform intended to accelerate drug development and commercialization for biopharmaceutical companies. The company uses a digital platform to find patients with serious diseases and connect them to clinical trials, disease databases, market research and disease awareness efforts, providing biopharmaceutical companies with a rare and important asset of disease database to develop patient-focused clinical research programs.
Generating Revenue
Acquired/Merged (Operating Subsidiary)
Private Equity-Backed